Back to all studies
RecruitingNCT05962216

Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders

This recruiting study focuses on depression and currently lists sites or participation links in Hong Kong.

DepressionOtherFrom 18 Years to 65 Years
In plain English

Key information made simple

This study exists to learn from real-world information that can show how this type of care fits into care. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Queen Mary Hospital in Hong Kong. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually being able to understand the study and consent, while common reasons not to take part include other factors that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT05962216. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Hong Kong.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com